Fuse Medical appoints new CFO

Fuse Medical announced today that it appointed Lawrence “Larry” S. Yellin as its new chief financial officer and member of its executive board.

Yellin will be responsible for the Richardson, Texas-based orthopedic device company’s financial functions, including accounting, audit, treasury, corporate finance, SEC reporting and investor relations.

A veteran of more than 25 years in financial management, business leadership and corporate strategy, Yellin served as CFO for NVIP, a holistic health and wellness supplier and manufacturer. Before NVIP, he was CFO for Logic E Cigarettes, VP Controller for Handy & Harman and CFO for Fujifilm’s consumer imaging group.

“We are pleased to welcome Mr. Yellin to our executive team and believe that Larry’s experiences in corporate strategy, financial expertise, and SEC background will make him an excellent fit for Fuse,” Fuse CEO Christopher C. Reeg said in a news release. “As Fuse continues …

Read more
  • 0

Dentsply CFO Jorge Gomez leaves to assume same role at Moderna

Moderna (Nasdaq:MRNA) announced today that it appointed Jorge Gomez as its new chief financial officer.

Gomez resigned as CFO of Dentsply Sirona (Nasdaq:XRAY), effective May 6, to assume the same role at Cambridge, Massachusetts-based Moderna. He will join effective May 9.

Get the full story at our sister site, Drug Discovery & Development.

Read more
  • 0

Boston Scientific’s Medsurg President David Pierce to retire

Boston Scientific (NYSE:BSX) announced that David A. Pierce, EVP and president of medsurg and endoscopy, will retire.

Pierce notified the company on March 30, 2022, that he intended to retire. The retirement will be made effective on July 4, 2022.

According to a news release, Pierce has been with Boston Scientific since 1991, serving in a number of roles of “increasing responsibility.” Over the months that follow until his retirement is made official, Pierce intends to lead efforts to transition his responsibilities to his successors.

Boston Scientific EVP and President of the Asia Pacific region, Arthur C. Butcher, will change roles to serve as EVP and group president of both medsurg and Asia Pacific while remaining an executive officer of the company, Boston Scientific said.

Michael Jones, who currently serves as VP and GM of endoscopy, will serve as SVP and president of endoscopy. All changes to roles will be effective as of May 2, …

Read more
  • 0

Meddux appoints new director of business development

[Image from Meddux]

Meddux announced today that it appointed Margery Parsell as its director of business development.

Parsell previously held the role of business development consultant for The Parsell Group, having worked with contract design services and manufacturing organizations including TDC Medical, Vention Medical, AdvancedCath, TE Medical and Aran Biomedical before that.

She holds more than 25 years in the medical device industry and brings knowledge of the development and manufacturing of complex and innovative devices in cardiology, structural heart, MIS devices, robotics, wearables and energy-based therapeutics, according to a news release.

“We are excited to have Margery join our team as a full-time employee,” Meddux President Dave Schechter said in the release. “Margery’s primary goal will be to serve our current clients, improve communications, and to identify and implement business…

Read more
  • 0

Channel Medsystems makes three appointments to management team including new CFO

Channel Medsystems announced today that it appointed three new members to its executive team, including a new chief financial officer.

Berkeley, California-based Channel Medsystems named Ian Vawter as VP and CFO, Rebecca Furlong as VP and president of U.S. sales and Nital Patel Bryant as senior director of marketing.

Channel Medsystems develops the Cerene cryotherapy device for treating menstrual bleeding. The next-generation platform received FDA approval in July 2020 and the company said in a news release that the appointments follow a successful early commercial launch in September 2021.

Vawter joins with 25 years of financial experience, Channel Medsystems said, having most recently served as VP and CFO at Tepha, which was acquired by BD.

Furlong carries nearly three decades of experience in medical devices and pharmaceuticals, the company said, including work in women’s health. She most recently served as area VP of sales at Takeda.

Read more
  • 0

Alberto Mas, president of BD’s medical segment, set to retire down this year

Alberto Mas [Image from BD]BD (NYSE:BDX) announced today that EVP and president of the company’s medical segment, Alberto Mas, will retire later this year.

Mas, 60, informed the company of his intent to retire in a move that will be made effective at the end of BD’s fiscal year on Sept. 30, 2022.

Franklin Lakes, N.J.-based BD said in a news release that it intends to name a successor to Mas prior to his official retirement date.

“Throughout his BD career, Alberto has demonstrated superb strategic ability, talent development, global perspective and an unwavering drive to deliver results in the right way,” BD Chairperson, CEO and President Tom Polen said in the release. “I want to express BD’s sincere gratitude to Alberto for his countless contributions to BD, health care providers and patients around the world, and we will miss his discipline, commitment to innovation and focus on execution. We wish him all the best in his…

Read more
  • 0

BrainCheck appoints new chief financial, revenue officers

BrainCheck announced today that it appointed Trey Swain as its chief financial officer and Matthew Cerullo as chief revenue officer.

Houston-based BrainCheck, which develops rapid, mobile cognitive assessment and decision support technology, said in a news release that the personnel announcement follows a $10 million Series B funding round completed in November 2021 as the company commits to “world-class executive management and long-term strategic growth.”

Swain joins having most recently served as consulting CFO and SVP of finance at Consero Global. His background covers scaling companies from pre-revenue startups to multimillion-dollar corporations. Having led more than 35 acquisitions on the buy and sell side, Swain is expected to lead BrainCheck to further growth and expansion.

Cerullo most recently worked with sales processes and growth at Real Time Medical Systems, where he worked clo…

Read more
  • 0

ApiJect appoints former WHO director as chief global health officer

ApiJect Systems announced today that Edward Kelley has joined as chief global health officer for the company.

Kelley will take on the role at Stamford, Connecticut-based ApiJect, which provides a platform for pharmaceutical companies to fill-finish their injectable medicines in prefilled delivery systems, as well as become a leader of its related organizations, ApiLabs and the ApiJect Global Initiative.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Cala Health announces new chief commercial, financial officers amid leadership expansion

Cala Health announced today that it expanded its leadership team with a number of appointments, including new chief commercial and financial officers.

New executives joining the company — which develops bioelectronic medicines to provide new therapies for chronic diseases — hold experience from major players in the medtech space, including iRhythm, Johnson & Johnson, Boston Scientific, Medtronic, Google and more.

The company also announced a new, larger headquarters in San Mateo, California. Cala designed the larger, LEED-certified building to support its growth as a flexible workspace with a high-functioning manufacturing and fulfillment center.

Joining Cala as chief commercial officer (CCO) is Doug Biehn, who most recently served as EVP of marketing at iRhythm. He was also COO at AliveCor and chief marketing officer at Blue Shield of California.

“I’m excited to be part of such an innovative and patient-centric company that is freeing people …

Read more
  • 0

Colfax announces board of directors for fabrication tech spinoff ESAB

Colfax (NYSE:CFX) today announced the setup of the board of directors for its previously announced fabrication technology spinoff.

Wilmington, Delaware-based Colfax announced last year that it plans to split into two publicly traded companies in 2022, with businesses including DJO forming a new stand-alone orthopedic device company called Enovis while the other company, called ESAB, will focus on fabrication technology operating out of Colfax’s Annapolis Junction, Maryland, headquarters.

Following the spinoff, which Colfax expects to consummate on April 4, the ESAB fabrication technology company will operate under the leadership of chairperson of the board, Mitchell P. Rales, according to a news release.

“Setting ESAB on a path for success and growth has been a priority since we first announced the separation,” Colfax President and CEO Matt Trerotola said in the release. “We have identified an incredibly talented and knowledgeable board of directors who …

Read more
  • 0

Vicarious Surgical names VP of operations

Vicarious Surgical this week announced that it appointed John Mazzola as VP of operations.

Mazzola brings more than 30 years of global operations and engineering management experience to the Waltham, Massachusetts-based surgical robotics company. He will be responsible for leading the strategic manufacturing plans for the Vicarious system as development progresses.

“We are excited to welcome John to our team as our vice president of operations,” said Adam Sachs, CEO and cofounder of Vicarious Surgical. “John’s deep operational and engineering expertise will be invaluable as we plan, develop, and execute upon our manufacturing strategies, processes, and procedures to bring next generation robotics to minimally invasive surgery.”

Prior to joining Vicarious, Mazzola was a VP of operations at Becton Dickinson Surgery where he oversaw a network of 10 manufacturing sites, a business planning and procurement organization, an advanced manufacturing engineering t…

Read more
  • 0

Visura Technologies announces CEO as it prepares to commercialize its cardio tech

Visura Technologies announced today that Christine Horton has assumed the role of president and CEO at the medical device company.

Minneapolis-based Visura develops state-of-the-art visualization solutions for improving the quality and efficiency of transesophageal echocardiogram (TEE) probe intubation.

The company said in a news release that Horton takes on the leadership position as Visura prepares for the U.S. commercialization efforts for its TEECAD system. Visura designed the FDA-cleared TEECAD system as a disposable camera that connects to TEE probes to offer physicians real-time visualization during esophageal intubation, improving probe placement for TEE procedures.

Horton holds 30 years of commercialization experience, having led startups and mid-sized companies, with her past roles including CEO at CoreSpine, where she raised capital, published data and led the company through FDA clearance.

“This is a pivotal t…

Read more
  • 0